Is Zevalin a radiopharmaceutical?

What exactly is Zevalin?

Yes. Zevalin is a radiopharmaceutical therapy. It uses a radioactive isotope to target cancer cells, and the product is designed to be administered as a drug along with its radiation component [1].

How does it work as a radiopharmaceutical?

Zevalin delivers radiation directly to cells by attaching a cancer-targeting antibody (ibritumomab) to a radioactive payload (yttrium-90). Patients receive the radiolabeled agent, which emits radiation to damage cancer cells [1].

Is it an imaging agent or a therapeutic radiopharmaceutical?

Zevalin is a therapeutic radiopharmaceutical, not an imaging-only radiotracer. Its purpose is to treat cancer by delivering radiation to tumor cells [1].

Sources

[1] https://www.drugs.com/zyvalin.html